This grand round has already taken place.
Update on Type 2 Diabetes Management: The Heart of the Matter
Dates and Times
Start: 10/16/2019 7:45 AM
End: 10/16/2019 8:45 AM
1) Learn about cardiovascular risk reduction associated with use of anti diabetic drugs in the class of GLP-1 receptor agonists
2) Learn bout the cardiovascular risk reduction associated with the use of anti-diabetic drugs in the class of SGLT2 inhibitors
3) prevention of adverse reactions associated with GLP-1 Receptor agonists and SGLT2 inhibitors
4) How to prevent increased cardiovascular risk associated with T2DM
Lecture Hall 2
101 Nicolls Road
Stony Brook, NY 11794
The School of Medicine, State University of New York at Stony Brook, is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The School of Medicine, State University of New York at Stony Brook designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit(s) ™. Physicians should only claim the credit commensurate with the extent of their participation in the activity.
Maintenance of Certification
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.00 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.